In assisted reproductive clinics, many women around age 40 or with diminished ovarian reserve share a common concern:
When ovarian function declines, many worry: Is the success rate already too low? Is there any way to improve?
In recent years, functional medicine has turned attention to a substance—NAD+—and is exploring it as an adjunct therapy to help improve the energy status of eggs. So, what exactly is NAD+? Does it really help?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme naturally present in the human body, widely involved in cellular energy metabolism.
Simply put, it is a "key coenzyme" for mitochondria.
Mitochondria are the "power plants" of the cell.
Egg cells are among the most energy-demanding cells in the body: fertilization requires energy, cell division requires energy, and embryo development requires energy.
If mitochondrial function within the egg declines, energy supply may be insufficient, potentially affecting fertilization rates and embryo development quality.
Therefore, one theory suggests that appropriate supplementation with NAD+ may help improve mitochondrial function, thereby enhancing the egg's energy status.
Many women ask: "Isn't the number of eggs fixed from birth? Can new eggs really grow?"
Indeed, the total egg count is limited. However, in each cycle, the antral follicles visible on ultrasound are only a subset.
At an earlier stage, there are preantral follicles that are not visible on ultrasound.
Through interventions that improve the ovarian environment, it may be possible to help these follicles become activated and enter the growth phase.
This is not "creating new eggs out of thin air," but rather activating follicles that already exist but were not recruited.
Therefore, after intervention, some individuals may observe:
In some clinical observations from fertility centers, for women with diminished ovarian reserve who received NAD+ infusion, the following trends have been noted:
In isolated cases:
Of course, it must be emphasized that these are clinical observations and not everyone will experience the same results. Individual differences remain significant.
In practice, a common schedule is:
The goal is to improve egg energy status before stimulation and to maintain support throughout the process.
Age is one of the most important factors affecting egg quality.
Generally speaking:
But the prerequisite is—as long as you have not reached menopause, follicular development may still occur.
Whether it is appropriate to try depends on a comprehensive assessment including: AMH level, baseline follicle count, hormone profile, and previous response to stimulation.
NAD+ is a naturally occurring substance in the human body.
In theory, supplementation involves "replenishing a substance already present in the body."
However, it is important to note:
Currently, NAD+ is considered an adjunct therapy in reproductive medicine, not a standard first-line treatment.
It is best understood as a supportive approach aimed at improving mitochondrial function in individuals with diminished ovarian reserve.
It is not:
But for some individuals with clear egg quality issues, repeated PGT failures, or diminished ovarian reserve, it may be a direction worth discussing.
When ovarian function declines, the core issues to address are often: egg quantity, egg quality, and embryo developmental potential.
Mitochondrial function is an important factor in egg quality. NAD+, as a key coenzyme in mitochondrial metabolism, is being used by some clinicians to support egg energy status.
Whether it is suitable for you depends on an individualized assessment.
In reproductive medicine, there is no "miracle cure," but every detail improved may add a fraction of possibility to success.